• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Dermatology

Hypertension and use of β-blockers linked to increased risk of psoriasis

byAngela WangandAdam Whittington
July 6, 2014
in Dermatology
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. A history of hypertension for 6 or more years was linked with an increased risk of psoriasis in US women. 

2. Women with regular β-blocker usage were at higher risk of psoriasis than those who had never used β-blockers. 

Evidence Rating Level: 2 (Good) 

Study Rundown: Psoriasis is a systemic disease associated with chronic inflammation secondary to T-cell-immune-mediated hyperproliferation of keratinocytes.  It has been associated with an increased risk of hypertension and cardiovascular disease, but data involving the elevated risk of psoriasis as a result of hypertension and medication use has been limited.  Thus, the authors sought to address this hypothesis and found that women with chronic hypertension of 6 or more years were more likely to develop psoriasis than normotensive women.  Additionally long-term use of β-blockers may also be associated with increased risk of psoriasis.  Strengths of this study included the use of registered nurses as the population, which added to the accuracy and validity of self-reported results.  However, this same feature may have limited the study’s generalization to other populations.

Click to read the study in JAMA Dermatology

Relevant Reading: Psoriasis Provoked or Exacerbated by Medications, Identifying Culprit Drugs

In-Depth [prospective cohort]: This study followed 843 incident psoriasis cases in female registered nurses between the ages of 30 and 55 years using the Nurses’ Heath Study.  Physician-diagnosed hypertension and regular antihypertensive medication use were reported and assessed using biennial questionnaires.  Additionally, covariates such as weight, smoking, cardiovascular disease, hypercholesterolemia, type 2 diabetes mellitus, menopausal status, postmenopausal hormone use, nonsteroidal anti-inflammatory drug use, multivitamin use, height, body mass index, alcohol intake, and physical activity were collected through follow-ups.  Cox proportional hazards regression model analysis was used to estimate incident psoriasis associated with hypertension and medications.  Results indicated that women with chronic hypertension of 6 years or more were at a higher risk of developing psoriasis when compared to normotensive women (HR, 1.27; 95% CI, 1.03-1.57).  This remained true for women who regularly took antihypertensive medications and for those who did not.  Lastly, women who specifically took β-blockers for 6 or more years were found to be at higher risk for developing psoriasis (HR, 1.39; 95% CI, 1.11-1.73, P = 0.009).

RELATED REPORTS

Bimekizumab is effective for active psoriatic arthritis in biologic-naïve adults

Prevalence, awareness, treatment, and control of hypertension in China

Chlorthalidone is not superior to hydrochlorothiazide in preventing hypertension-related cardiovascular events

More from this author: Video-based behavioral intervention benefits clinical skin examinations, Biofilm-producing staphylococci occlude eccrine sweat ducts in atopic dermatitis, Initial primary invasive or in situ melanoma increases risk of subsequent invasive melanoma, Various factors impact quality of life in patients with chronic pruritus, New Mohs sterilization guidelines may not affect infection rates

Image: PD 

©2012-2014 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT.

Tags: beta blockerhypertensionpsoriasis
Previous Post

The TORCH trial: Combination of salmeterol and fluticasone in treating COPD [Classics Series]

Next Post

Home self-sonograms for assisted reproduction comparable to in-office imaging

RelatedReports

Long-term use of apremilast for psoriasis associated with an acceptable safety profile
Chronic Disease

Bimekizumab is effective for active psoriatic arthritis in biologic-naïve adults

January 24, 2023
Prevalence of hypertension among adolescents varies by race and BMI
Cardiology

Prevalence, awareness, treatment, and control of hypertension in China

January 20, 2023
Preterm birth associated with cardiovascular risk factors in adolescence
Cardiology

Chlorthalidone is not superior to hydrochlorothiazide in preventing hypertension-related cardiovascular events

January 4, 2023
Prevalence of hypertension among adolescents varies by race and BMI
Cardiology

Aprocitentan is an effective and safe option for the treatment of resistant hypertension

December 14, 2022
Next Post
Mortality risk associated with low-birth weight

Home self-sonograms for assisted reproduction comparable to in-office imaging

Increased risk of hookah use in urban and high socioeconomic adolescents

Increased risk of hookah use in urban and high socioeconomic adolescents

Discharge diagnoses in the E.R. cannot retrospectively identify non-emergent visits

Limited knowledge, high interest in pediatric advanced directives among caregivers

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Catheter ablation reduces rates of persistent atrial fibrillation and atrial tachyarrhythmia
  • Deep intronic FGF14 repeat expansion associated with late-onset cerebella ataxia
  • Plant-based diets may be associated with lower risk of aggressive prostate cancer
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options